Abstract. Hepatocellular carcinoma (HCC) is a highly malignant tumor with an extremely poor prognosis. Our preliminary study indicated that bufalin could restrain the proliferation of human hepatoma BEL-7402 cells in a time-and dosedependent manner. In the present study, the colony formation assay, the Transwell invasion assay, the western blot analysis and the immunofluorescence method were respectively used to investigate the effect and mechanism of bufalin against HCC cell invasion and metastasis. We found that: i) bufalin had significant inhibitory effect on the cell proliferation of BEL-7402 cells; ii) bufalin markedly inhibited the migration and invasion of BEL-7402 cells; iii) bufalin could suppress the phosphorylation of GSK-3β Ser9 site in BEL-7402 cells, decrease the expression of β-catenin, cyclin D1, metalloproteinases-7 (MMP-7) and cyclooxygenase-2 (COX-2) in the cytoplasm, and increase the expression of E-cadherin and β-catenin on the cell membrane; and iv) the expression of α-fetoprotein significantly decreased and the expression of albumin increased in BEL-7402 cells after bufalin was used. Our results indicate that: i) bufalin can regulate the expression of associated factors in Wnt/β-catenin signaling pathway of BEL-7402 cells through suppressing the phosphorylation of GSK-3β Ser9 site; ii) bufalin can strengthen intercellular E-cadherin/β-catenin complex to control epithelial-mesenchymal transition; and iii) bufalin can reverse the malignant phenotype and promote the differentiation and maturation by regulating the AFP and ALB expression in BEL-7402 cells. These are very important mechanisms of bufalin on the inhibition of the invasion and metastasis of HCC cells.
Introduction
Hepatocellular carcinoma (HCC) accounts for 90-95% of all kinds of liver cancers, with nearly 500,000 new patients each year. It is a common malignant tumor in the digestive system, and the incidence is ranked the sixth of all cancers in the world. Patients with HCC are often diagnosed in the late stages due to the undetectable onset, so the overall prognosis is poor, making it the third ranked based on mortality in the world (1) (2) (3) (4) . Partial hepatectomy is currently preferred to treat HCC. However, only less than 30% of patients with HCC can finally be operated, because 60-90% of the patients have viral hepatitis and liver cirrhosis. Furthermore, the recurrence rate is 80% after operation at five years, it seriously affects the surgical curative effect (1, 5, 6) . Although liver transplantation can cure liver cancer without considering the cirrhosis condition and improve the total 5-year survival rate to 70-80%, it is restricted to be carried out widely because of high technical requirements, the shortage of graft source for transplantation, and the risk of health damage to donors during living donor liver transplantation and other disadvantages (5, 7) . In order to get good therapeutic effects, all criteria of liver transplantation have limitations on the number and size of the tumors, the vascular invasion and the distant metastasis (8) . Chemical or thermal ablation, radiotherapy, transcatheter arterial chemoembolization, drug treatment are palliative therapeutic modalities for advanced liver cancer, but they still have many disadvantages, such as impaired organic function, bone marrow suppression and drug resistance (5) .
As one of the main components of antitumor traditional Chinese medicine from toad venom, bufalin has been confirmed to have antitumor activity, which has an obviously inhibiting role in various kinds of blood and solid malignancies including liver cancer (9) . In recent research it is shown that bufalin is able to reverse multi-drug resistance of HCC cells and strengthen the ability of sorafenib to suppress proliferation of HCC cells (10, 11) . Our preliminary study indicated that bufalin could restrain the proliferation of human hepatoma BEL-7402 cells in a time-and dosedependent manner and the IC 50 value of 72 h was 0.085 µg/ ml. Yet, the mechanism of inhibiting the proliferation, invasion and metastasis of HCC cells by bufalin still remains
The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell invasion and metastasis via Wnt/β-catenin signaling pathway (12) . The abnormal activation of Wnt/β-catenin signaling pathway plays an important role in the occurrence and development of many tumors (13) . Multiple antitumor drugs resist HCC cells through regulating the activity of Wnt/β-catenin signaling pathway (14) (15) (16) . The anti-HCC cell effect of bufalin correlating with the abnormal activation of Wnt/β-catenin signaling pathway is unclear.
The expression of associated factors in Wnt/β-catenin signaling pathway of human hepatoma BEL-7402 cells, α-fetoprotein (AFP) and albumin (ALB) protein expression are, respectively, detected after bufalin is used in vitro. The present study aims to reveal the mechanism of bufalin against the proliferation, invasion and metastasis of HCC cells. Clony formation assay. BEL-7402 cells growing in log phase were seeded into 60-mm dishes at a density of 2,000 cells/dish. After cultured for 24 h, the cells were treated with bufalin (0.05 µg/ml) in vitro. The medium was replaced with fresh medium containing bufalin every 3 days. Nine days later, the culture medium was removed and cell colonies were stained with 0.1% crystal violet. Colonies including <15 cells and faintly stained cells were ignored. The number of colonies in 10 random fields was counted under an inverted microscope (Carl Zeiss, Oberkochen, Germany).
Materials and methods

Materials
Cell migration assay. After cultured with bufalin (0.085 µg/ml) for 72 h and with serum-free RPMI-1640 medium for 12 h in vitro, BEL-7402 cells were harvested and prepared to 1x10 6 /ml cell suspension in serum-free RPMI-1640 medium. RPMI-1640 medium (600 µl) with 10% fetal calf serum (FBS) was added into the lower chamber of the Transwell (Corning Incorporated, Corning, NY, USA), and 100 µl of cell suspension was added into the upper chamber. The experiment was performed in triplicate. After incubated at 37̊C with 5% CO 2 for 24 h, the cells that did not migrate through the membrane were gently removed. Cells that migrated through the membrane were stained with 0.1% crystal violet. Six fields were randomly selected and observed under the inverted microscope for stained cell number counting and image collection.
Cell invasion assay. After the culture with bufalin (0.085 µg/ml) for 72 h and with serum-free RPMI-1640 for 12 h in vitro, BEL-7402 cells were harvested and prepared to 1x10 6 /ml cell suspension in serum-free RPMI-1640 medium. RPMI-1640 (600 µl) with 10% FBS was added into the lower chamber of the Transwell, and 100 µl of cell suspension was added into the upper chamber with a filter coated with 100 µl Matrigel at 1:8 dilutions in serum-free medium. The experiment was performed in triplicate. After incubated at 37℃ with 5% CO 2 for 48 h, the cells that did not invade the membrane were gently removed. Cells that invaded the membrane were stained with 0.1% crystal violet. Six fields were randomly selected and observed under an inverted microscope for counting the cell number of stained cells and image collection.
Quantitative analysis of proteins in Wnt/β-catenin signaling pathway and E-cadherin/β-catenin complex in BEL-7402
cells. BEL-7402 cells were treated with bufalin (0.085 µg/ml) for 72 h, then rinsed with ice-cold 0.01 M PBS, cell lysis solution containing protease inhibitors was added. After cell lysis, lysis suspension was collected and centrifuged at 4˚C with speed of 16,000 x g for 15 min to draw off supernatant solution. Afterwards, microplate reader (Bio-Rad Laboratories Inc., Hercules, CA, USA) was used to measure the absorbance value of protein samples and the reference standard samples in BCA protein quantitative kit at ~562 nm, and then protein contents in various groups were calculated. The protein content in unit volume of extract was balanced, using 0.01 M PBS as supplement. Protein solution was mixed with 5X loading buffer at 1:4 ratio, then the protein mixture was denatured in water bath at 100˚C for 5 min in the various groups. Electrophoretic separation was conducted using 10% SDS polyacrylamide gels. The protein bands after electrophoresis were transferred to polyvinylidene fluoride (PVDF) membrane which was blocked with western blocking solution for 1 h. Then this membrane was, respectively, incubated in monoclonal antibodies APC (1:500), E-cadherin (1:500), cyclin D1 (1:500), MMP-7 (1:500), COX-2 (1:500), GSK-3β (1:500), β-catenin (1:500), p-GSK-3β Ser9 (1:500) and β-actin (1:1,000) at 4˚C for 18 h. Then, the membrane was rinsed with PBST three times and incubated in IgG (H+L) at 37˚C for 2 h. The PVDF membrane was again rinsed with PBST three times prior to treatment with enhanced chemiluminescence western blotting detection kit (Amersham Biosciencse, Piscataway, NJ, USA). The images of protein bands were visualized on X-ray film (Kodak, Rochester, NY, USA) and analyzed with the Bio-Rad Quantity One software (Bio-Rad Laboratories) 3 times.
Localization of proteins in Wnt/β-catenin signaling pathway and E-cadherin/β-catenin complex in BEL-7402 cells.
BEL-7402 cells were treated with bufalin (0.085 µg/ml) for 72 h in vitro, and then cells were treated with PBS-Triton solution (40 ml PBS + 0.1% Triton 50 µl), rinsed with 0.01 M PBS. The processed cells were, respectively, incubated with rabbit anti-human monoclonal antibodies APC (1:100), E-cadherin (1:100), cyclin D1 (1:100), MMP-7 (1:100), COX-2 (1:100), GSK-3β (1:100), β-catenin (1:100) and p-GSK-3β Ser9 (1:100) at 4˚C for 18 h. Afterwards, the cells were rinsed and incubated with fluorescent-labeled goat anti-rabbit IgG at 37˚C for 2 h. The cell nucleus was stained with DAPI, then observed by a fluorescent inverted microscope (Carl Zeiss) for image collection and analysis.
Quantitative analysis of AFP and ALB expression in BEL-7402 cells. BEL-7402 cells were treated with bufalin (0.085 µg/ml) for 1 week, then rinsed with ice-cold 0.01 M PBS, and cell lysis solution containing protease inhibitors was added. After cell lysis, lysis suspension was collected and centrifuged at 4˚C with speed of 16,000 x g for 15 min to draw off supernatant solution. Then, microplate reader was used to measure the absorbance value of protein samples and the reference standard samples in BCA protein quantitative kit at ~562 nm, and then protein contents in various groups were calculated. The protein content in unit volume of extract was balanced, using 0.01 M PBS as supplement. Protein solution was mixed with 5X loading buffer at 1:4 ratio, then the protein mixture was denatured in water bath at 100˚C for 5 min in various group. Electrophoretic separation was conducted using 10% SDS polyacrylamide gels. The protein bands after electrophoresis were transferred to PVDF membrane which was blocked with western blocking solution for 1 h. The membrane was then, respectively, incubated in monoclonal antibodies AFP (1:500), ALB (1:500) and β-actin (1:1,000) at 4˚C for 18 h. The membrane was rinsed with PBST three times and incubated in IgG (H+L) at 37˚C for 2 h. The PVDF membrane was again rinsed with PBST three times prior to photographic developing and fixing. Digital images of protein bands were obtained using ChemiDoc system and analyzed with the Bio-Rad Quantity One software 3 times.
Statistical analysis. The SPSS 19.0 statistical software (IBM, Armonk, NY, USA) was used for statistical processing. Quantitative variables were expressed by mean ± SD and analyzed with t-test. P-value <0.05 was considered statistically significant.
Results
Effect of bufalin on colony formation of HCC cells.
The number of the colonies in the bufalin group (0.05 µg/ml) was lower than that of control group (Fig. 1A) . The colonies formed in bufalin group (0.05 µg/ml) and the cells in colonies of bufalin group were clearly less than those of control group under microscope (Fig. 1B) . Quantitative analysis of the colonies showed that compared with the control group, the colony formation ability of BEL-7402 cells was significantly inhibited by bufalin (P<0.05; Fig. 1C ).
Influence of bufalin on migration and invasion of HCC cells.
Compared with the control group, the migration and invasion ability of the BEL-7402 cells was significantly inhibited by bufalin ( Fig. 2A and C) . Quantitative analysis of the migrating and invasive cells showed that compared with the control group, the migration and invasion number of BEL-7402 cells having been treated with bufalin (0.085 µg/ml) for 72 h was reduced significantly (both P<0.05; Fig. 2B and D) .
Effect of bufalin on the protein expression and localization of β-catenin in HCC cells. Compared with the control group, the protein expression of β-catenin in BEL-7402 cells of bufalin group after exposure to bufalin (0.085 µg/ml) for 72 h decreased significantly (P<0.05) ( Table I and Fig. 3A) .
The immunofluorescence imaging showed that β-catenin mainly localized in the cytoplasm and nuclei of BEL-7402 cells in the control group. After exposure to bufalin (0.085 µg/ ml) for 72 h, the fluorescence intensity of β-catenin increased Table I significantly on cell membrane, whereas the fluorescence intensity of β-catenin decreased in the cytoplasm and nuclei of BEL-7402 cells (Fig. 3B) .
Effect of bufalin on the protein expression of p-GSK-3β
Ser9, E-cadherin, APC and GSK-3β in wnt/β-catenin signal pathway of HCC cells. Compared with the control group, the protein expression of p-GSK-3β Ser9 in BEL-7402 cells of the bufalin group after exposure to bufalin (0.085 µg/ml) for 72 h decreased significantly. The protein expression of E-cadherin in BEL-7402 cells increased significantly after bufalin treatment (P<0.05). The protein expression of APC and GSK-3β in BEL-7402 cells was not significantly different between the control group and the bufalin group (P>0.05) ( Table I and Fig. 4A ). The immunofluorescence imaging showed that compared with the control group, the fluorescence intensity of p-GSK-3β Ser9 in the cytoplasm decreased (Fig. 4B) , and the fluorescence intensity of E-cadherin on cell membrane increased after exposure to bufalin (0.085 µg/ml) for 72 h (Fig. 4C) . Whereas the fluorescence intensity of APC and GSK-3β in cytoplasm was, respectively, not significantly different between the bufalin group and the control group ( Fig. 4D and E) .
Effect of bufalin on the protein expression of MMP-7, COX-2, and cyclin D1 in the downstream molecules of wnt/β-catenin signal pathway in HCC cells.
Compared with the control group, the protein expression of MMP-7, COX-2 and cyclin D1 in BEL-7402 cells of bufalin group after exposure to bufalin (0.085 µg/ml) for 72 h decreased significantly (P<0.05) (Table I and Fig. 5A ).
The immunofluorescence imaging showed that when compared with the control group, the fluorescence intensity of MMP-7, COX-2 and cyclin D1 in cytoplasm of BEL-7402 cells decreased after exposure to bufalin (0.085 µg/ml) for 72 h (Fig. 5B-D) . 
Effect of bufalin on the protein expression of AFP and ALB in HCC cells.
Compared with the control group, the protein expression of AFP in BEL-7402 cells of bufalin group after exposure to bufalin (0.085 µg/ml) for 1 week obviously decreased, and the expression levels of ALB increased significantly (both P<0.05) (Table II and Fig. 6 ).
Discussion
Intracellular signal transduction pathway is a complex network system that transduces extracellular signals into intracelluar downstream molecules. However, these accurately regulating signal networks occur some abnormal change in malignant tumor cells as a result of gene mutation, which eventually results in a series of changes in cellular metabolism and the occurrence of new features. The change of cell signaling pathway can give rise to various malignant behavior, such as uncontrollable proliferation, anti-apoptosis, invasion and metastasis of tumor cells (17, 18) .
Wnt signaling pathway plays a crucial role in embryonic development and tissue stability (19) . To date, Wnt signaling pathway is classified into two categories: canonical Wnt pathway and non-canonical Wnt pathway. The activation of non-canonical Wnt pathway does not rely on the participation of β-catenin, including Wnt/Ca 2+ pathway and Wnt/PCP pathway (20) . Wnt/β-catenin pathway, known as a canonical Wnt signaling pathway, consists of Wnt signaling ligands, Fz receptor family, and co-receptor lipoprotein receptorrelated proteins 5 and 6 (LRP5/6), disheveled (Dsh), axin, β-catenin, APC, casein kinase 1a and GSK-3β. Among them, β-catenin acts as the key protein in function implementation of Wnt/β-catenin signaling pathway, β-catenin accumulation in cytoplasm predicts that Wnt/β-catenin pathway is in the activated state. In normal mature cells, due to lack of Wnt factor stimulation, most of β-catenin combines with E-cadherin on cell membrane, while a small amount of free β-catenin will be quickly phosphorylated in degradation complex (consisting of APC, axin and GSK-3β), modified by ubiquitin and then hydrolyzed by protease. In this case, the quantity of free casein kinase 1a-catenin in cytoplasm usually remains at a very low level. As required in embryonic development or tissue regeneration, receptor complexes on cell membrane (including Fz receptor family and co-receptor LRP5/6) will combine with extracellular Wnt factors, and degrade the degradation complex under the mediation of Dsh protein. Thus, β-catenin will accumulate in cytoplasm and pass through the nuclear membrane to conjugate with transcription factor/lymphoid enhancer-binding factor (TCF/LEF) in the nucleus, then activate the transcription of downstream target protein genes that are related to cell proliferation, apoptosis, matrix dissolution and angiogenesis, such as cyclin D1, MMP-7, COX-2, c-myc, survivin and vascular endothelial growth factor (VEGF) (21) (22) (23) . Among these downstream target proteins, the cyclin D1 can regulate and control the cell transformation from G1 phase to S phase to interfere with the process of cell proliferation, by combining with cyclin-dependent kinase and activating it in G1 phase (24) . MMP-7, a member of the family of matrix metalloproteinases, is not only involved in various extracellular matrix lysis, but also can damage diversified tumor-suppressor compositions on the cell surface (25) . COX-2 can suppress tumor cell apoptosis, promote tumor cell proliferation, stimulate matrix metalloproteinases production and enhance tumor cell invasion and metastasis abilities (26) . The overexpression of cyclin D1, MMP-7 and COX-2 plays an important role in the proliferation, invasion and metastasis of liver cancer (27) (28) (29) . The abnormal activation of Wnt/β-catenin signal pathway has important biological effects on the occurrence and development of primary liver cancer (30) . E-cadherin, mainly expressed in epithelial cells, can combine with intracellular β-catenin, and form a connected composite structure to participate in maintaining cell-cell and cell-extracellular matrix adhesion stability. Therefore, the low expression of E-cadherin will result in a prominent increase of free β-catenin in the cytoplasm (31) . GSK-3β, the main function domain of complex degradation, possesses two phosphorylation sites with opposite regulating effects (including Tyr216 and Ser9). Phosphorylated Tyr216 can strengthen GSK-3β activity, while phosphorylated Ser9 site will lead to GSK-3β deactivation (32) . The higher phosphorylation at GSK-3β ser9 site and lower expression of E-cadherin is regarded as major causes of activation of Wnt/β-catenin pathway in HCC cells (33) . In addition, epithelial-mesenchymal transition (EMT) also plays a key role in cancer metastasis process. As a phenotypic conversion, EMT promotes embryonic development and organ formation. However, EMT makes polar epithelial cells to convert into mesenchymal cells, increasing the loss of tight junctions between cells, promotes metastasis, invasion and enhances the anti-apoptotic ability of cells (34, 35) .
In the present study, through clone formation assay, we verified our previous experimental results that bufalin could inhibit HCC cell proliferation. In order to further explore the anti-HCC effect of bufalin, the tumor invasion and metastasis environment in vitro were established through Transwell on cell membrane, whereas, decreased the local expression of β-catenin in the cytoplasm and the nuclei of BEL-7402 cells, decreased the expression of p-GSK-3β Ser9 in the cytoplasm, increase the expression of E-cadherin and β-catenin on the cell membrane of BEL-7402 cells, decreased the expression of cyclin D1, MMP-7 and COX-2 in cytoplasm of BEL-7402 cells. It indicated that bufalin could inhibit the phosphorylation of GSK-3β Ser9 site and translocation of β-catenin in HCC cells, then influenced the extranuclear signal transduction and endonuclear target molecules, ultimately resulting in lower expressions of cyclin D1, MMP-7 and COX-2 in HCC cells. It might be an important biological mechanism of bufalin by which it inhibits the HCC cell proliferation, invasion and metastasis. Since bufalin increased the expression of E-cadherin and β-catenin on the cell membrane, the quantity of E-cadherin/β-catenin complex increased as well. The complex between cells is an important factor to maintain the stability of the epithelial cells, having an inhibitory effect on EMT during the metastasis of tumor cells (37) . Based on considerable research, when the EMT of tumor cells are restricted, the invasion and metastasis ability of tumor cells markedly decrease (38) (39) (40) . Thus, enhancing the stability between the membrane of epithelial cells and inhibiting the EMT are also important mechanisms by which bufalin inhibits the HCC cell invasion and migration.
AFP develops during fetal development, the AFP concentration decreases rapidly after birth. In normal adult, the AFP concentration is very low, and AFP gene is in a hermit state, but will be activated when high quantity of HCC cells appear. Thus, it is used widely in clinical diagnosis of HCC, and it is an important malignant phenotype of HCC cells. The overexpression of AFP is often associated with HCC metastasis, vascular invasion, and other related malignant behavior (41, 42) . In contrast with AFP, ALB produced by the liver cells has an important role in maintaining body's normal physiological activities (43) . Determination of ALB synthesis reflects liver cell function and it is an indicator of liver cancer cell differentiation in vitro (44, 45) . Recent studies have found that AFP can promote cell growth of HCC while ALB inhibits HCC cell proliferation (46, 47) . After bufalin was added into HCC cells in vitro, the result showed that bufalin could significantly decrease expression of AFP, while bufalin increased expression of ALB in BEL-7402 cells. It indicates that bufalin reverses the cell malignant phenotype, promoting cell differentiation and maturation, and regulating the expression of AFP and ALB in BEL-7402 cells, thus, suggesting that bufalin could inhibit the malignant biological behavior of HCC cells.
In conclusion, metastasis of malignant tumors is a continuous complicated process, including the tumor growth in the original site, cells invading into the body circulation after EMT, and replantation into the new organ tissue from the circulatory system followed by proliferation (48, 49) . Our research results show that by inhibiting GSK-3β Ser9 site phosphorylation, bufalin weakened the activity of the Wnt/β-catenin signaling pathway. By increasing inter-membrane E-cadherin/β-catenin complex, bufalin inhibited the EMT of HCC cells. It indicates that they are the key mechanisms of bufalin against cell proliferation, invasion and metastasis of HCC cells. However, due to poor water solubility, high toxicity, and short half-life the clinical application of bufalin is restricted (50) . It is necessary to further develop and prepare the new drug dosage form of bufalin such as nano-drugs via combining bufalin with polymer nano-carrier, the new dosage form can not only reduce the bufalin toxicity, but also have slow-release and active targeting properties. The present study provide very important theoretical basis for further developing the new molecular targeted drugs aimed at specific site of the Wnt/β-catenin signaling pathway. The new dosage form of bufalin and molecular targeted drugs will improve the anti-HCC effects of bufalin.
